secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2022-02-18T23:59:59+00:00
Accession:  0001558370-22-001442
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path director resigns; board fails Nasdaq independence rules, cure period granted
--------------------------------------------------------------------------------

- Martina Molsbergen resigned from board and all committees effective Feb 14, 2022, not due to disagreement.
- Company no longer has majority independent directors or three independent audit committee members as required by Nasdaq.
- Cure period expires at earlier of next annual meeting or Feb 14, 2023; board plans to appoint new independent director.
- Non-compliance notified to Nasdaq on Feb 15, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000155837022001442/0001558370-22-001442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000155837022001442/bpth-20220214x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-001442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer